Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Equity Average (2021 - 2025)

Incannex Healthcare's Equity Average history spans 4 years, with the latest figure at $75.2 million for Q4 2025.

  • For Q4 2025, Equity Average rose 1889.87% year-over-year to $75.2 million; the TTM value through Dec 2025 reached $75.2 million, up 1889.87%, while the annual FY2025 figure was $12.3 million, N/A changed from the prior year.
  • Equity Average for Q4 2025 was $75.2 million at Incannex Healthcare, up from $45.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $75.2 million in Q4 2025 and bottomed at $3.8 million in Q4 2024.
  • The 4-year median for Equity Average is $12.7 million (2024), against an average of $19.7 million.
  • The largest annual shift saw Equity Average plummeted 80.45% in 2024 before it soared 1889.87% in 2025.
  • A 4-year view of Equity Average shows it stood at $5.9 million in 2021, then soared by 229.37% to $19.3 million in 2023, then tumbled by 80.45% to $3.8 million in 2024, then skyrocketed by 1889.87% to $75.2 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Equity Average are $75.2 million (Q4 2025), $45.2 million (Q3 2025), and $10.4 million (Q2 2025).